| Medical Mutual | Oncology Value (Intravenous) | 2026-08-04 |
| Medical Mutual | Oncology Value (Intravenous) | 2026-08-04 |
| Medical Mutual | Fulvestrant: CligavyxTM, Faslodex® (Intramuscular) | 2026-08-04 |
| Medical Mutual | Enhanced Oncology Value: IVIG (immune globulin IV): (EOV) | 2026-08-04 |
| Medical Mutual | Oncology Value: Keytruda Qlex™ (pembrolizumab and berahyaluronidase alfa-pmph) | 2026-08-04 |
| Medical Mutual | Oncology Value: Keytruda® (pembrolizumab) (Intravenous) (EOV) | 2026-08-04 |
| Medical Mutual | Oncology Value: Leqvio® (inclisiran) (Subcutaneous) | 2026-08-04 |
| Medical Mutual | Levonorgestrel-releasing Intrauterine Systems: Mirena®, Skyla®, Liletta®, Kyleena® (Intrauterine) | 2026-08-04 |
| Medical Mutual | Navelbine® (vinorelbine) (Intravenous) | 2026-08-04 |
| Medical Mutual | Enhanced Oncology Value: Opdivo Qvantig™ (nivolumab and hyaluronidase-nvhy) (EOV) | 2026-08-04 |